AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca cumulative patients reached by Patient Access & Affordability programmes (millions) (M)
Sustainability Data Annex — Access to Healthcare
Latest, FY2025
14.7
Period ended Dec 31, 2025
Change on a year earlier
+3.5%
14.2 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cumulative patients reached by Patient Access & Affordability programmes (millions) (M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14.7 | +3.5% | Sustainability Data Annex 2025 ↗ |
| FY2024 | Dec 31, 2024 | 14.2 | +3.6% | Sustainability Data Annex 2025 ↗ |
| FY2023 | Dec 31, 2023 | 13.7 | +6.8% | Sustainability Data Annex 2025 ↗ |
| FY2022 | Dec 31, 2022 | 12.8 | – | Sustainability Data Annex 2024 ↗ |
Cite this data
StockData. (2026). AstraZeneca Cumulative patients reached by Patient Access & Affordability programmes (millions) (M), annual FY2022–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/esg_patient_afford
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.